Ionis Pharmaceuticals Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

80.16 -0.63

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

80.2

Max

82.41

Pagrindiniai rodikliai

By Trading Economics

Pajamos

136M

-93M

Pardavimai

43M

246M

Pelnas, tenkantis vienai akcijai

-0.3

Pelno marža

-37.599

Darbuotojai

1,402

EBITDA

-4.7B

-69M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+29.64% upside

Dividendai

By Acuity

Kitas uždarbis

2026-07-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

759M

13B

Ankstesnė atidarymo kaina

80.79

Ankstesnė uždarymo kaina

80.16

Naujienos nuotaikos

By Acuity

50%

50%

111 / 342 reitingas Healthcare

Ionis Pharmaceuticals Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-06-29 23:31; UTC

News
Social Media

Comcast shares are higher in after-market trading amid reports of a potential expansion into video games and plans for AI-focused data centers.

2026-06-29 23:26; UTC

Social Media
News

Micron Technology shares are lower after hours amid mixed sentiment and legal challenges over alleged memory chip production manipulation, despite revenue rising to $41.5 billion.

2026-06-29 23:16; UTC

News

O'Reilly Automotive Inc shares are lower in after-market hours, following a slight decline since Monday's close amid a ranking rise in the S&P 500.

2026-06-29 23:11; UTC

News
Correlated Moves

The GBP/HKD is higher today, reaching the upper end of its daily range amid market volatility from renewed U.S.-Iran hostilities ahead of talks in Doha.

2026-06-29 23:06; UTC

News
ETF Constituents

Investor caution persists amid U.S.-Iran tensions, with the Vanguard Growth ETF showing little change in after-market trading. Microsoft leads contributors with a 0.85% return.

2026-06-29 23:06; UTC

News

Regeneron Pharmaceuticals will join the FDA's PreCheck Pilot Program to enhance domestic drug manufacturing. Shares are trading lower in after-market hours.

2026-06-29 23:06; UTC

News

U.S. West Texas Intermediate futures rose to $70.51 per barrel after a U.S.-Iran agreement eased tensions, supporting United States Oil Fund LP in after-market trading.

2026-06-29 23:06; UTC

News

Piper Sandler initiated coverage of PayPal with a Neutral rating and a price target of $42.00. Shares were roughly flat in after-market hours.

2026-06-29 23:02; UTC

News
ETF Constituents
Macro News
Correlated Moves

The Dow Jones Industrial Average closed above 52,000, driven by a rebound in technology stocks. The Vanguard Information Technology ETF showed little change in after-market hours.

2026-06-29 20:07; UTC

News

The USD/THB is lower as optimism grows over U.S.-Iran talks after military exchanges. The asset remains above its 20-day moving average.

2026-06-29 20:07; UTC

News
Correlated Moves

Ethereum is trading higher, supported by easing Middle East tensions and Bitmine's acquisition of 27,084 ETH, raising its total holdings to 5.7 million ETH.

2026-06-29 20:07; UTC

Correlated Moves
Social Media
News
ETF Constituents

Positive sentiment for the SPDR Dow Jones Industrial Average ETF Trust follows a halt in U.S.-Iran military actions, easing geopolitical tensions and supporting stock futures.

2026-06-29 20:07; UTC

Social Media
News

Intel shares are higher as Cantor Fitzgerald raises its price target to $150, indicating a recovery from early session lows.

2026-06-29 20:07; UTC

News

Positive economic indicators and easing U.S.-Iran tensions boost the Nikkei 225 Index higher during after-market hours, with retail sales rising 5.3% year-on-year.

2026-06-29 20:07; UTC

News

USD/ZAR is trading lower as optimism over U.S.-Iran talks eases energy supply concerns. This marks the third consecutive session of declines.

2026-06-29 20:07; UTC

News
Correlated Moves

USD/PLN is lower today, influenced by a decline in the US Dollar Index and improved sentiment from U.S.-Iran relations.

2026-06-29 20:07; UTC

News
Correlated Moves

Gold prices are lower today amid renewed U.S.-Iran tensions and potential Federal Reserve interest rate hikes. Crude oil's rise may diminish gold's safe-haven appeal.

2026-06-29 20:07; UTC

Social Media
Correlated Moves
News

Trading lower amid a declining US Dollar Index; JPMorgan's blockchain impact.

2026-06-29 20:07; UTC

News
Correlated Moves

USD/DKK is trading lower as the US Dollar Index declines. Renewed optimism over U.S.-Iran relations is also influencing market sentiment.

2026-06-29 20:07; UTC

Correlated Moves
News

USD/CZK declines amid a falling US Dollar Index, reflecting volatility in today's session. The pair remains above its 20-day moving average.

2026-06-29 20:06; UTC

News
Correlated Moves

Microchip Technology Inc is rising amid positive momentum in the semiconductor sector, supported by strength in the broader market and a favorable analyst consensus.

2026-06-29 20:06; UTC

Correlated Moves
News

Gold prices are lower today amid renewed U.S.-Iran tensions and concerns over potential Federal Reserve interest rate hikes. Crude oil prices have surged as well.

2026-06-29 20:06; UTC

Correlated Moves
News

USD/NOK is trading lower amid optimism over U.S.-Iran relations, despite remaining above its 20-day moving average. The US Dollar Index has also declined.

2026-06-29 20:04; UTC

ETF Constituents
Correlated Moves
Social Media
News

SPDR S&P 500 ETF Trust advances as U.S. and Iran agree to halt military strikes, boosting market sentiment ahead of a diplomatic summit in Doha.

2026-06-29 20:04; UTC

ETF Constituents
Social Media
News
Correlated Moves

Invesco QQQ Trust rises as U.S.-Iran tensions ease, boosting market sentiment. Strong performance from Amazon and Tesla supports the ETF's advance since Friday.

2026-06-29 20:03; UTC

Social Media
News

Tesla Inc. shares are higher today amid positive delivery forecasts and the closure of an NHTSA investigation into power steering issues.

2026-06-29 20:03; UTC

News
Correlated Moves

Alphabet Inc shares are higher today, supported by increased call volume and a favorable Supreme Court ruling easing regulatory concerns for tech companies.

2026-06-29 20:03; UTC

News
Correlated Moves
Social Media
ETF Constituents

The Communication Services Select Sector SPDR Fund is gaining today, driven by strong performances from GOOGL and META amid a broader tech rally.

2026-06-29 20:03; UTC

Social Media
News

GameStop is pursuing a $56 billion bid for eBay, despite rejection. eBay shares are trading higher amid acquisition discussions and technical platform issues.

2026-06-29 20:03; UTC

Correlated Moves
Social Media
News

Amazon.com Inc. is advancing, supported by a market rally and a new partnership with Park Ha Biological to enhance personal care product offerings.

Akcijų palyginimas

Kainos pokytis

Ionis Pharmaceuticals Inc Prognozė

Kainos tikslas

By TipRanks

29.64% į viršų

12 mėnesių prognozė

Vidutinis 104.61 USD  29.64%

Aukščiausias 130 USD

Žemiausias 75 USD

Remiantis 19 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Ionis Pharmaceuticals Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

19 ratings

17

Pirkti

2

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

111 / 342 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an antisense injection for the treatment of polyneuropathy caused by hereditary transthyretin amyloidosis in adults; and WAYLIVRA, an antisense medicine for treatment for familial chylomicronemia syndrome (FCS) and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of ATTR; Olezarsen for patients with FCS and severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Tofersen to inhibit the production of superoxide dismutase 1; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Bepirovirsen to inhibit the production of viral proteins associated with hepatitis B virus. In addition, the company develops IONIS-FB-LRx to inhibit the production of complement factor B and the alternative complement pathway; and ION224 to reduce the production of diacylglycerol acyltransferase 2. It has a strategic collaboration with Biogen for the treatment of neurological disorders; and collaboration and license agreement with Metagenomi, Inc, AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis, Roche, Swedish Orphan Biovitrum AB, and PTC Therapeutics. The company was incorporated in 1989 and is based in Carlsbad, California.
help-icon Live chat